ELF1 exhibits heightened expression in glioma tissues and exhibits a close correlation with WHO grading and patient Karnofsky Performance Status (KPS) scores, suggesting its potential role as a tumor-promoting factor (62). The gene discussed is ELF1; the disease is central nervous system cancer.